Launched in February 2012, We Work for Health Virginia is comprised of nearly 25 organizations including the Virginia Chamber of Commerce, Virginia BIO, the Fairfax Chamber of Commerce, The National Federation of Independent Business (NFIB) Virginia, the Greater Washington Board of Trade, the Medical Society of Virginia, the MS Society, the Lupus Foundation of America, Leukemia-Lymphoma Society, Rx Partnership, the Psychiatric Society of Virginia, and the Arthritis Foundation.  

Our chairs include Barry DuVal, President and CEO of the Virginia Chamber of Commerce, Jeff Gallagher, CEO of VABIO, former Senator Edd Houck and Mark Herzog, Vice President, kaleo. 

Coalition members have recently met with Senators Tim Kaine and Mark Warner, and Congressmen Brat, Goodlatte and Griffith. We have hosted events with Governor Terry McAuliffe and Governor McDonnell, and have highlighted the economic impact of the 3,400 clinical trials that have taken place in Virginia since 1999.  These clinical trials have helped to fight the 6 most chronic diseases facing Virginians: cancer, stroke, diabetes, heart disease, asthma and mental illness.

The biopharmaceutical sector is the foundation of one of Virginia’s most dynamic innovation and business ecosystems. Not only does the industry invest heavily in the research and development of new treatments and cures, it also generates high quality jobs, powers economic output and exports for the U.S. economy and sustains a very large-scale supply chain.


Supporting High Quality Jobs in Virginia

The innovative biopharmaceutical sector directly supported 10,137 jobs in Virginia in 2015. These jobs are often high-skill, high-wage professions.

The industry also supported another 37,358 jobs indirectly, for a total of about 47,495 jobs across the Virginia economy. These additional jobs are with vendors and suppliers such as construction companies and I.T. companies, and jobs generated by the sector’s employees such as day care centers and restaurants.

Virginia workers whose jobs were supported by the biopharmaceutical sector paid a total of $715 million in personal taxes in 2015—$629.7 million in federal taxes and $85.3 million in state taxes.

Virginia's Economic Impact

In 2015, the biopharmaceutical sector supported $12 billion in economic output for the state of Virginia—including $5.2 billion generated directly by the sector, and another $6.8 billion through its vendors and suppliers and through the economic activity of its workforce.

Direct Output per Direct Employee in 2015

$5.2 Billion
$6.8 Billion
$12.0 Billion

vendor relationships


vendor spending


Find Your
Elected Officials



Barry DuVal, President and CEO, Virginia Chamber of Commerce

Jeff Gallagher, CEO, VirginiaBio

Former Senator Edd Houck

Mark Herzog, Vice President, kaléo Pharma


American Cancer Society

American Heart Association

American Lung Association

American Urological Association

Arthritis Foundation

AMPEL Biosolutions

Center for Rural Virginia

Dulles Regional Chamber of Commerce

Greater Washington Board of Trade

Immune Deficiency Foundation

kaléo Pharma

Leukemia & Lymphoma Society of Virginia

Lupus Foundation of America DC/MD/VA Chapter

Medical Society of Virginia 

NAMI Virginia

National Multiple Sclerosis Society Central Virginia

National Patient Advocate Foundation

Neurofibromatosis Foundation- Mid-Atlantic

NFIB - Virginia Chapter

Northern Virginia Chamber of Commerce

Patient Services Inc

Prevent Blindness Mid-Atlantic

Psychiatric Society of VA

Rx Partnership

Technology Hampton Roads

The Virginia Hispanic Chamber of Commerce

Virginia BIO

Virginia Breast Cancer Foundation

Virginia Commonwealth University

Virginia Chamber of Commerce

Virginia Hemophilia Foundation


If your organization is interested in joining We Work For Health Virginia, please click the "Join" button and fill out our form.